Ozempic is FDA-approved for type 2 diabetes management
Comparing Delilah to Competitors in the GLP-1 Weight Loss Treatment Space In the competitive 2025 market of GLP-1 weight loss providers, Delilah distinguishes itself with transparent pricing, medical-grade protocols, and outcomes-focused coaching
Rinne P, Silvola JM, Hellberg S, et al
(Source: Stanford Medicine, 2026) Some Sellers Lacked Proper Licensing The same study noted that some compounding facilities lacked licenses to perform sterile compounding or had recently faced disciplinary actions from state pharmacy boards meaning the risk wasnt limited to the drug formulation itself, but extended to the basic manufacturing conditions
Salo, P
As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control